Background and AimsThere is a demand for additional data regarding the impact of coronavirus disease 2019 (COVID‐19) on the pediatric population. This study sought to determine the clinical and epidemiological features of pediatric COVID‐19 in Iran.MethodsA retrospective study was performed to assess medical records of children with COVID‐19 admitted to Abuzar Hospital in Ahvaz (Iran). Their clinical and demographic data were recorded.ResultsIn this study, 600 medical records of pediatric COVID‐19 patients were evaluated. Over 50% of them were boys. Mild, moderate, and severe manifestations of COVID‐19 were identified in 250, 200, and 150 children, respectively. Patients with severe or moderate COVID‐19 had substantially higher levels of various inflammatory markers (C‐reactive protein (CRP), fibrinogen, and d‐dimer), alanine transaminase (ALT), creatine kinase (CPK), blood urea nitrogen (BUN), neutrophils, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), creatinine (Cr), bilirubin, and gamma‐glutamyl transferase (GGT) compared to children with mild COVID‐19 (p < 0.001); they also had lower levels of lymphocytes, hemoglobin (Hb), and vitamin D than patients with mild COVID‐19 (p < 0.001). In addition, children with severe or moderate COVID‐19 had a notably higher incidence of fever or dry cough and longer hospital stays than those with mild COVID‐19 (p < 0.001). The prevalence of malnutrition and anemia in patients was 50.6% and 31.5%, respectively. A significant proportion of children who were underweight and stunted experienced moderate to severe COVID‐19. Furthermore, there was a considerably higher prevalence of malnutrition, anemia, and vitamin D insufficiency, or deficiency in children with moderate‐to‐severe COVID‐19 compared to patients with mild COVID‐19 (p < 0.001).ConclusionThe outcomes of this study revealed a significantly higher prevalence of malnutrition, anemia, vitamin D insufficiency or deficiency, elevated liver and kidney function test results, and increased inflammatory markers in children with moderate to severe COVID‐19 compared to those with mild COVID‐19.